The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Minimally Modified LDL Binds to CD14, Induces Macrophage Spreading via TLR4/MD-2, and Inhibits Phagocytosis of Apoptotic Cells
Open accessAbstract
Minimally modified low density lipoprotein (mmLDL) is a pro-inflammatory and pro-atherogenic lipoprotein that, unlike profoundly oxidized LDL (OxLDL), is not recognized by scavenger receptors and thus does not have enhanced uptake by macrophages. However, here we demonstrate that mmLDL (as well as OxLDL) induces actin polymerization and spreading of macrophages, which results in such pro-atherogenic consequences as inhibition of phagocytosis of apoptotic cells but enhancement of OxLDL uptake. We also demonstrate for the first time that the lipopolysaccharide receptor, CD14, and toll-like receptor-4/MD-2 are involved in these mmLDL effects. Macrophages of the J774 cell line exhibited higher mmLDL binding and F-actin response than its CD14-deficient mutant, LR-9 cells. Similarly, Chinese hamster ovary cells transfected with human CD14 specifically bound mmLDL and responded with higher F-actin compared with control cells. Macrophages from C3H/HeJ mice, which have a point mutation in the Tlr4 gene, responded with lower F-actin to mmLDL and did not spread as well as macrophages from control animals. A significantly higher F-actin response was also observed in Chinese hamster ovary cells transfected with human toll-like receptor-4/MD-2 but not with TLR4 alone or TLR2. Thus, in addition to inhibition of phagocytosis, the recognition of mmLDL by macrophage lipopolysaccharide receptors results in convergence of cellular immune responses to products of microorganisms and to oxidation-specific self-antigens, which could both influence macrophage function and atherogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
The phosphoinositide 3-kinase pathway
Cantley, L. C. (2002) · Science · doi:10.1126/science.296.5573.1655 · Cited by 5,621
Toll-like receptors and innate immunity
Medzhitov, R. (2001) · Nature Reviews Immunology · doi:10.1038/35100529 · Cited by 4,308
Specificity and mechanism of action of some commonly used protein kinase inhibitors
DAVIES, S. P., REDDY, H., CAIVANO, M., & COHEN, P. (2000) · Biochemical Journal · doi:10.1042/bj3510095 · Cited by 3,132
Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,051
Self-citationLPS induction of gene expression in human monocytes
Guha, M., & Mackman, N. (2001) · Cellular Signalling · doi:10.1016/s0898-6568(00)00149-2 · Cited by 2,304
PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL
Tontonoz, P., Nagy, L., Alvarez, J. G. A., Thomazy, V. A., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81575-5 · Cited by 1,797
Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus
Kurt-Jones, E. A., Popova, L., Kwinn, L., Haynes, L. M., Jones, L. P., Tripp, R. A., Walsh, E. E., Freeman, M. W., Golenbock, D. T., Anderson, L. J., et al. (2000) · Nature Immunology · doi:10.1038/80833 · Cited by 1,683
Ohashi, K., Burkart, V., Flohé, S., & Kolb, H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.558 · Cited by 1,606
Synthesis and Function of 3-Phosphorylated Inositol Lipids
Vanhaesebroeck, B., Leevers, S. J., Ahmadi, K., Timms, J., Katso, R., Driscoll, P. C., Woscholski, R., Parker, P. J., & Waterfield, M. D. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.535 · Cited by 1,535
Toll-like receptors control activation of adaptive immune responses
Schnare, M., Barton, G. M., Holt, A. C., Takeda, K., Akira, S., & Medzhitov, R. (2001) · Nature Immunology · doi:10.1038/ni712 · Cited by 1,365
Toll-like Receptor 4 Polymorphisms and Atherogenesis
Kiechl, S., Lorenz, E., Reindl, M., Wiedermann, C. J., Oberhollenzer, F., Bonora, E., Willeit, J., & Schwartz, D. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012673 · Cited by 1,024
Minimally modified low density lipoprotein stimulates monocyte endothelial interactions.
Berliner, J. A., Territo, M. C., Sevanian, A., Ramin, S., Kim, J. A., Bamshad, B., Esterson, M., & Fogelman, A. M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114562 · Cited by 925
Edfeldt, K., Swedenborg, J., Hansson, G. K., & Yan, Z.-Q. (2002) · PubMed · Cited by 847
Edfeldt, K., Swedenborg, J., Hansson, G. K., & Yan, Z.-Q. (2002) · Circulation · doi:10.1161/circ.105.10.1158 · Cited by 707
Shaw, P. X., Hörkkö, S., Chang, M.-K., Curtiss, L. K., Palinski, W., Silverman, G. J., & Witztum, J. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8472 · Cited by 676
Self-citationXu, X. H., Shah, P. K., Faure, E., Equils, O., Thomas, L., Fishbein, M. C., Luthringer, D., Xu, X.-P., Rajavashisth, T. B., Yano, J., et al. (2001) · Circulation · doi:10.1161/hc5001.100631 · Cited by 666
Toll-like receptor 2–mediated NF-κB activation requires a Rac1-dependent pathway
Arbibe, L., Mira, J.-P., Teusch, N., Kline, L., Guha, M., Mackman, N., Godowski, P. J., Ulevitch, R. J., & Knaus, U. G. (2000) · Nature Immunology · doi:10.1038/82797 · Cited by 664
Hörkkö, S., Bird, D. A., Miller, E., Itabe, H., Leitinger, N., Subbanagounder, G., Berliner, J. A., Friedman, P., Dennis, E. A., Curtiss, L. K., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4533 · Cited by 559
Self-citationToll-like receptors as adjuvant receptors
Kaisho, T., & Akira, S. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(01)00182-3 · Cited by 492
Chang, M.-K., Bergmark, C., Laurila, A., Hörkkö, S., Han, K.-H., Friedman, P., Dennis, E. A., & Witztum, J. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6353 · Cited by 459
Self-citationPfeiffer, A., Böttcher, A., Orsó, E., Kapinsky, M., Nagy, P., Bodnár, A., Spreitzer, I., Liebisch, G., Drobnik, W., Gempel, K., et al. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200111)31:11<3153::aid-immu3153>3.0.co;2-0 · Cited by 401
Protective role of phospholipid oxidation products in endotoxin-induced tissue damage
Bochkov, V. N., Kadl, A., Huber, J., Gruber, F., Binder, B. R., & Leitinger, N. (2002) · Nature · doi:10.1038/nature01023 · Cited by 367
Kawasaki, K., Akashi, S., Shimazu, R., Yoshida, T., Miyake, K., & Nishijima, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2251 · Cited by 355
Dansky, H. M., Charlton, S. A., Harper, M. M., & Smith, J. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4642 · Cited by 346
Schissel, S. L., Tweedie-Hardman, J., Rapp, J. H., Graham, G., Williams, K. J., & Tabas, I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118934 · Cited by 341
Hubacek, J. A., Pit’ha, J., Škodová, Z., Stanĕk, V., & Poledne, R. (1999) · Circulation · doi:10.1161/01.cir.99.25.3218 · Cited by 327
Jiang, Q., Akashi, S., Miyake, K., & Petty, H. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.7.3541 · Cited by 320
MD-2 Binds to Bacterial Lipopolysaccharide
Viriyakosol, S., Tobias, P. S., Kitchens, R. L., & Kirkland, T. N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105228200 · Cited by 312
Self-citationLiao, F., Andalibi, A., deBeer, F. C., Fogelman, A. M., & Lusis, A. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116495 · Cited by 299
Huh, H., Pearce, S., Yesner, L., Schindler, J., & Silverstein, R. (1996) · Blood · doi:10.1182/blood.v87.5.2020.2020 · Cited by 269
Minimally modified low density lipoprotein is biologically active in vivo in mice.
Liao, F., Berliner, J. A., Mehrabian, M., Navab, M., Demer, L. L., Lusis, A. J., & Fogelman, A. M. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115261 · Cited by 213
Napoli, C., Quehenberger, O., De Nigris, F., Abete, P., Glass, C. K., & Palinski, W. (2000) · The FASEB Journal · doi:10.1096/fj.99-0986com · Cited by 199
Friedman, P., Hörkkö, S., Steinberg, D., Witztum, J. L., & Dennis, E. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108860200 · Cited by 195
Self-citationEvidence for a Role of Phospholipid Oxidation Products in Atherogenesis
Berliner, J. (2001) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00098-6 · Cited by 182
Reardon, C. A., Blachowicz, L., White, T., Cabana, V., Wang, Y., Lukens, J., Bluestone, J., & Getz, G. S. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.6.1011 · Cited by 181
Infectious Agents Are Not Necessary for Murine Atherogenesis
Wright, S. D., Burton, C., Hernandez, M., Hassing, H., Montenegro, J., Mundt, S., Patel, S., Card, D. J., Hermanowski-Vosatka, A., Bergstrom, J. D., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.8.1437 · Cited by 176
Shi, W., Haberland, M. E., Jien, M.-L., Shih, D. M., & Lusis, A. J. (2000) · Circulation · doi:10.1161/01.cir.102.1.75 · Cited by 174
Requirement for Rho GTPases and PI 3-kinases during apoptotic cell phagocytosis by macrophages
Leverrier, Y., & Ridley, A. J. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00047-1 · Cited by 163
Apoptosis in atherosclerosis: focus on oxidized lipids and inflammation
Martinet, W., & Kockx, M. M. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200110000-00009 · Cited by 128
Ropert, C., de Almeida, I. C., Closel, M., Travassos, L. R., Ferguson, M. A. J., Cohen, P., & Gazzinelli, R. T. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.5.3423 · Cited by 124
Benz, D., Mol, M. J. T. M., Ezaki, M., Mori-Ito, N., Zelán, I., Miyanohara, A., Friedmann, T., Parthasarathy, S., Steinberg, D. H., & Witztum, J. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.5191 · Cited by 107
Self-citationSchmidt, A., Caron, E., & Hall, A. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.2.438-448.2001 · Cited by 102
A Region of Human CD14 Required for Lipopolysaccharide Binding
Viriyakosol, S., & Kirkland, T. N. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.1.361 · Cited by 101
Self-citationNakamura, I., Lipfert, L., Rodan, G. A., & Duong, L. T. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.2.361 · Cited by 95
Lougheed, M., & Steinbrecher, U. P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.20.11798 · Cited by 94
Wang, P., Kitchens, R. L., & Munford, R. S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.38.24309 · Cited by 93
Schlegel, R., Krahling, S., Callahan, M. K., & Williamson, P. (1999) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400529 · Cited by 80
Miller, Y. I., Chang, M.-K., Funk, C. D., Feramisco, J. R., & Witztum, J. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011276200 · Cited by 77
Self-citationFibroblasts That Overexpress 15-Lipoxygenase Generate Bioactive and Minimally Modified LDL
Sigari, F., Lee, C., Witztum, J. L., & Reaven, P. D. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.12.3639 · Cited by 70
Self-citationLipoperoxides in LDL incubated with fibroblasts that overexpress 15-lipoxygenase.
Ezaki, M., Witztum, J. L., & Steinberg, D. H. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41117-4 · Cited by 64
Self-citationLee, C., Sigari, F., Segrado, T., Hörkkö, S., Hama, S. Y., Subbaiah, P. V., Miwa, M., Navab, M., Witztum, J. L., & Reaven, P. D. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.6.1437 · Cited by 63
Self-citationMine, S., Tabata, T., Wada, Y., Fujisaki, T., Iida, T., Noguchi, N., Niki, E., Kodama, T., & Tanaka, Y. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00582-2 · Cited by 41
Soluble CD14 Mediates Efflux of Phospholipids from Cells
Sugiyama, T., & Wright, S. D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.826 · Cited by 34
Abate, A., & Schröder, H. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00031-9 · Cited by 30
Cited by
The immune system in atherosclerosis
Hansson, G. K., & Hermansson, A. (2011) · Nature Immunology · doi:10.1038/ni.2001 · Cited by 2,317
The immune response in atherosclerosis: a double-edged sword
Hansson, G. K., & Libby, P. (2006) · Nature Reviews Immunology · doi:10.1038/nri1882 · Cited by 2,182
Imai, Y., Kuba, K., Neely, G. G., Yaghubian-Malhami, R., Perkmann, T., van Loo, G., Ermolaeva, M., Veldhuizen, R., Leung, Y. H. C., Wang, H., et al. (2008) · Cell · doi:10.1016/j.cell.2008.02.043 · Cited by 1,356
Self-citationMasters, S. L., Dunne, A., Subramanian, S. L., Hull, R. L., Tannahill, G. M., Sharp, F. A., Becker, C., Franchi, L., Yoshihara, E., Chen, Z., et al. (2010) · Nature Immunology · doi:10.1038/ni.1935 · Cited by 1,330
Apoptotic cell clearance: basic biology and therapeutic potential
Poon, I. K. H., Lucas, C. D., Rossi, A. G., & Ravichandran, K. S. (2014) · Nature Reviews Immunology · doi:10.1038/nri3607 · Cited by 1,223
Metadata
- Authors
- Miller, Y. I., Viriyakosol, S., Binder, C. J., Feramisco, J. R., Kirkland, T. N., & Witztum, J. L.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-01
- Volume
- 278
- Issue
- 3
- Pages
- 1561-1568
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2018475901
- Cited by
- 399
- References
- 55
- FWCI
- 8.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.